144 related articles for article (PubMed ID: 17122988)
41. The intratumoral distribution of nuclear beta-catenin is a prognostic marker in colon cancer.
Horst D; Reu S; Kriegl L; Engel J; Kirchner T; Jung A
Cancer; 2009 May; 115(10):2063-70. PubMed ID: 19298008
[TBL] [Abstract][Full Text] [Related]
42. Prognostic factors relating to esophageal cancer.
Butsch J; Christein JD; Millikan K
Minerva Chir; 2002 Dec; 57(6):789-94. PubMed ID: 12592221
[TBL] [Abstract][Full Text] [Related]
43. Molecular alterations associated with bladder cancer initiation and progression.
Cordon-Cardo C
Scand J Urol Nephrol Suppl; 2008 Sep; (218):154-65. PubMed ID: 18815930
[TBL] [Abstract][Full Text] [Related]
44. Lymph node involvement in advanced gastroesophageal junction adenocarcinoma.
Pedrazzani C; de Manzoni G; Marrelli D; Giacopuzzi S; Corso G; Minicozzi AM; Rampone B; Roviello F
J Thorac Cardiovasc Surg; 2007 Aug; 134(2):378-85. PubMed ID: 17662776
[TBL] [Abstract][Full Text] [Related]
45. [Biomolecular markers in renal adenocarcinoma].
Tejido Sánchez A; Leiva Galvis O
Arch Esp Urol; 2002 May; 55(4):369-81. PubMed ID: 12094483
[TBL] [Abstract][Full Text] [Related]
46. [Molecular carcinogenesis of the upper gastrointestinal tract].
Höfler H; Becker KF; Keller G
Verh Dtsch Ges Pathol; 2003; 87():123-9. PubMed ID: 16888903
[TBL] [Abstract][Full Text] [Related]
47. Molecular biological challenges in he treatment of esophageal adenocarcinoma.
Boonstra JJ; Dinjens WN; Tilanus HW; Koppert LB
Expert Rev Gastroenterol Hepatol; 2007 Dec; 1(2):275-86. PubMed ID: 19072420
[TBL] [Abstract][Full Text] [Related]
48. Gene expression profiling of non-small-cell lung cancer.
Lacroix L; Commo F; Soria JC
Expert Rev Mol Diagn; 2008 Mar; 8(2):167-78. PubMed ID: 18366303
[TBL] [Abstract][Full Text] [Related]
49. Genetic variations in esophageal cancer risk and prognosis.
Cheung WY; Liu G
Gastroenterol Clin North Am; 2009 Mar; 38(1):75-91, viii. PubMed ID: 19327568
[TBL] [Abstract][Full Text] [Related]
50. P53 and EGFR expression in colorectal cancer: a reappraisal of 'old' tissue markers in patients with long follow-up.
Theodoropoulos GE; Karafoka E; Papailiou JG; Stamopoulos P; Zambirinis CP; Bramis K; Panoussopoulos SG; Leandros E; Bramis J
Anticancer Res; 2009 Feb; 29(2):785-91. PubMed ID: 19331236
[TBL] [Abstract][Full Text] [Related]
51. Bio-pathologic characteristics related to chromosome 11 aneusomy and cyclin D1 gene status in surgically resected stage I and II breast cancer: Identification of an adverse prognostic profile.
Mottolese M; Orlandi G; Sperduti I; Merola R; Buglioni S; Di Benedetto A; Pinnarò P; Perracchio L; Venturo I; Cognetti F; Cianciulli A
Am J Surg Pathol; 2007 Feb; 31(2):247-54. PubMed ID: 17255770
[TBL] [Abstract][Full Text] [Related]
52. Clinical implications of HER-2/neu overexpression and proteolytic activity imbalance in breast cancer.
Swellam M; Arab LR; Bushnak HA
IUBMB Life; 2007 Jun; 59(6):394-401. PubMed ID: 17613170
[TBL] [Abstract][Full Text] [Related]
53. Comparative histochemical evaluation of mucins expression in fetal esophagus and adenocarcinomas of the gastroesophageal junction.
Vernygorodskyi S; Rekun T; Zhuchenko P
Exp Oncol; 2018 Oct; 40(3):223-227. PubMed ID: 30285012
[TBL] [Abstract][Full Text] [Related]
54. Postoperative complications after esophagectomy for adenocarcinoma of the esophagus are related to timing of death due to recurrence.
Lagarde SM; de Boer JD; ten Kate FJ; Busch OR; Obertop H; van Lanschot JJ
Ann Surg; 2008 Jan; 247(1):71-6. PubMed ID: 18156925
[TBL] [Abstract][Full Text] [Related]
55. Predicting individual survival after potentially curative esophagectomy for adenocarcinoma of the esophagus or gastroesophageal junction.
Lagarde SM; Reitsma JB; Ten Kate FJ; Busch OR; Obertop H; Zwinderman AH; Moons J; van Lanschot JJ; Lerut T
Ann Surg; 2008 Dec; 248(6):1006-13. PubMed ID: 19092345
[TBL] [Abstract][Full Text] [Related]
56. Prognostic nomogram for patients undergoing oesophagectomy for adenocarcinoma of the oesophagus or gastro-oesophageal junction.
Lagarde SM; Reitsma JB; de Castro SM; Ten Kate FJ; Busch OR; van Lanschot JJ
Br J Surg; 2007 Nov; 94(11):1361-8. PubMed ID: 17582230
[TBL] [Abstract][Full Text] [Related]
57. Expression of epidermal growth factor receptor and cyclin D1 in pretreatment biopsies as a predictive factor of radiotherapy efficacy in early glottic cancer.
Chang AR; Wu HG; Park CI; Jun YK; Kim CW
Head Neck; 2008 Jul; 30(7):852-7. PubMed ID: 18302259
[TBL] [Abstract][Full Text] [Related]
58. Trends in management and prognosis for esophageal cancer surgery: twenty-five years of experience at a single institution.
Ruol A; Castoro C; Portale G; Cavallin F; Sileni VC; Cagol M; Alfieri R; Corti L; Boso C; Zaninotto G; Peracchia A; Ancona E
Arch Surg; 2009 Mar; 144(3):247-54; discussion 254. PubMed ID: 19289664
[TBL] [Abstract][Full Text] [Related]
59. Molecular biology of sporadic gastric cancer: prognostic indicators and novel therapeutic approaches.
Scartozzi M; Galizia E; Freddari F; Berardi R; Cellerino R; Cascinu S
Cancer Treat Rev; 2004 Aug; 30(5):451-9. PubMed ID: 15245777
[TBL] [Abstract][Full Text] [Related]
60. Clinical biology of esophageal adenocarcinoma after surgery is influenced by nuclear factor-kappaB expression.
Izzo JG; Malhotra U; Wu TT; Luthra R; Correa AM; Swisher SG; Hofstetter W; Chao KS; Hung MC; Ajani JA
Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1200-5. PubMed ID: 17548685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
